Mercury Bio’s yEV™ platform uses yeast-derived exosomes to deliver proteins across the blood-brain barrier, achieving neuron-specific delivery and offering new possibilities for treating neurological diseases...
Read More »Mercury Bio’s yEV™ platform uses yeast-derived exosomes to deliver proteins across the blood-brain barrier, achieving neuron-specific delivery and offering new possibilities for treating neurological diseases...
Read More »